Chemical agents

Information

  • Patent Grant
  • 4677204
  • Patent Number
    4,677,204
  • Date Filed
    Tuesday, December 7, 1965
    58 years ago
  • Date Issued
    Tuesday, June 30, 1987
    37 years ago
Abstract
1. A chemical toxic agent selected from the group consisting of: ##STR1## where n is an integer from 3 to 11 and X represents one equivalent of an ion.
Description

This invention relates to a series of new compounds that are extremely useful as chemical warfare agents.
The agents act mostly on the peripheral autonomic cholinergic nervous system. They interfere with the normal process of neuromuscular impulses from nerve to muscle. These compounds are extremely toxic at relatively low dose levels in various animals.
The object of this invention is to synthesize new lethal agents in high yield, wherein said products are well suited for industrial scale manufacture by means of a very simple procedure.





Other objects of and uses for the invention will in part be obvious and will in part appear hereinafter in the following detailed description thereof.
We have found that numerous compounds hereinafter set forth are effective toxic chemical agents. Advantageously, the agents are soluble in water, methanol and ethanol without any detrimental effects to said agent. Moreover, these agents are made by two distinct and economical methods.
In accordance with the invention, a solution of 2-dimethylaminomethyl-3-dimethylcarbamoxypyridine is allowed to react with an .alpha.,.omega.-dihalo-alkane, wherein the alkane radical has 3 to 11 carbon atoms, in the presence of sodium iodide and acetonitrile. The reaction is allowed to proceed for a period of six days at room temperature with formation of a crystalline material. This crystalline material is removed by filtration and triturated with acetone. The crude product is dissolved in hot ethanol and treated with charcoal. After the addition of ethyl acetate to the filtered solution, a crystalline product is formed, collected and dried.
A second method employed in this invention consists of reacting an .alpha.,.omega.-dihalo-alkane wherein the alkane radical consists of 3 to 11 carbon atoms, with 2-dimethylaminomethyl-3-dimethylcarbamoxypyridine in the presence of acetonitrile. This solution is heated on a steam bath for 6 hours and allowed to cool overnight at ambient temperature. The solution is filtered and the collected crystalline product is triturated with acetone. The product is dissolved in hot ethanol and treated with charcoal. Ethyl acetate is added to the filtered solution whereby a crystalline product is formed, collected and dried.
These compounds can be shown generically as follows: ##STR2##
Where n is an integer from 3 to 11 inclusive and where X is one equivalent of a monovalent or polyvalent anion.
The procedure used for the preparation of the new toxic materials is schematically shown as follows: ##STR3##
Where n is the same as above, X is a halide radical and X.sup.- is the corresponding halide anion, preferably chlorine or bromine.
In the above reaction, we have found that the incoming dihaloalkane adds to the nitrogen atom of the 2-dimethylaminomethyl moiety to the exclusion of the other nitrogen atoms because of the more basic nature of the former. If compounds are desired in which X is other than a halide ion, the above quaternary compounds are reacted with the desired acid by a simple exchange reaction as set forth below.
METHOD A
A solution of approximately 2 moles of 2-dimethylaminomethyl-3-dimethylcarbamoxypyridine, approximately one mole of .alpha.,.omega.-dihaloalkane, and a catalytic amount of sodium iodide in acetonitrile is allowed to stand at room temperature for six days. The crystalline material that is usually formed during the reaction period is removed by filtration and triturated with acetone. In the event no solid separates, ethyl acetate is added to precipitate the crude product, which is then dissolved in hot ethanol and treated with charcoal. Ethyl acetate is added to the filtered solution to precipitate the crystalline product, which is collected and dried.
METHOD B
A solution of approximately 2 moles of 2-dimethylaminomethyl-3-dimethylcarbamoxypyridine and approximately one mole of .alpha.,.omega.-dihaloalkane in acetonitrile is heated on a steam bath for 6 hours and allowed to stand overnight at room temperature. The crystalline product is collected by filtration and triturated with acetone. In the event no solid separates, ethyl acetate is added to precipitate the crude product, which is then dissolved in hot ethanol and treated with charcoal. Ethyl acetate is added to the filtered solution to precipitate the crystalline product, which is collected and dried.
The compounds that are representative of our invention are listed below by code number, name, and chemical structure. ##STR4##
We have shown preferred compounds in which the anion is limited to the halogen moiety, in particular the bromides, since the dibromoalkanes are readily available and are good quaternizing agents. In general, however, it is only necessary that the anions merely have to meet the requirement of being capable of forming a stable salt with the quaternary nitrogens. Thus, the halogen ion can be exchanged with other anions of a relatively strong monovalent or polyvalent acids by conventional methods. For example, if X is a bromide in the bis-quaternary compound, it can be treated with a basic ion exchange resin or mixed with silver oxide and subsequently the desired acid is added. In like manner the sulfate, nitrate, hydrogen, oxalate, perchlorate salts may be prepared. Representative examples of these additional monovalent or polyvalent bis quaternary compounds are:
1,8-bis[methyl-2-(3-dimethylcarbamoxypyridyl)methylamino]octane sulfate
1,8-bis[methyl-2-(3-dimethylcarbamoxypyridyl)methylamino]octane dinitrate
1,9-bis[methyl-2-(3-dimethylcarbamoxypyridyl)methylamino]nonane dihydrogenoxalate
1,9-bis[methyl-2-(3-dimethylcarbamoxypyridyl)methylamino]nonane diperchlorate
The examples shown in Table I are also illustrative of our invention but it is to be understood that the invention is not to be limited thereto since the scope of the appended claims defines our invention.
TABLE I__________________________________________________________________________ Meth- Toxicities od of Melting Analysis IV LD.sub.50EA Prepa- Point Soluble Calculated % Found % (mg/kg)Ex. No. ration .degree.C. Yield in C H O Br I C H O Br I Mice Rabbits__________________________________________________________________________1 4048 B 198-199 .sup. 42.sup.a Water 45.1 6.3 12.0 45.2 6.3 11.7 >32 >20 Methanol Ethanol2 4038 B 170-175 .sup. 36.sup.b Water 44.7 6.6 13.7 45.0 6.7 13.3 3.2 5.6 Methanol Ethanol3 4026 B 188-194 .sup. 44.sup.a Water 46.7 6.7 23.0 46.8 6.8 23.0 0.063 0.056 Methanol Ethanol4 3948 B 145-147 .sup. 67.sup.a Water 47.6 6.8 11.3 22.6 47.6 7.0 11.7 22.7 0.0178 0.0176 Methanol Ethanol5 4181 A 160-163 19 Water 49.4 6.8 22.7 49.4 6.9 22.6 0.013 0.0056 Methanol Ethanol6 3990 A,B 190-191 64 Water 50.1 7.0 22.2 50.1 7.2 22.3 0.0063 0.0026 Methanol Ethanol7 4056 B 100-105 95 Water 50.8 7.1 21.9 50.6 7.0 21.7 0.011 0.0027 Methanol Ethanol8 3887 A,B 198-199 73 Water 51.5 7.3 21.4 51.4 7.2 21.2 0.010 0.0042 Methanol Ethanol9 3887 A B 160-161 60 Water 45.7 6.5 30.2 45.5 6.2 30.0 0.010 0.005 Methanol Ethanol10 4057 A 130-132 62 Water 52.1 7.4 21.1 52.5 7.4 21.1 0.009 0.005 Methanol Ethanol__________________________________________________________________________ N.B. .sup.a Monohydrate .sup.b Dihydrate mg. = milligram kg. = kilogram weight of the animal LD.sub.50 = the dosage required to kill 50% of the test animals. IV = Intravenous
Claims
  • 1. A chemical toxic agent selected from the group consisting of: ##STR5## where n is an integer from 3 to 11 and X represents one equivalent of an anion.
  • 2. The salts of claim 1 wherein X is selected from the group of anions consisting of halide, sulfate, oxalate, nitrate, and perchlorate.
  • 3. The compound 1,3-bis[methyl-2-(3-dimethylcarbamoxypyridyl)methylamino]propane dimethobromide.
  • 4. The compound 1,4-bis[methyl-2-(3-dimethylcarbamoxypyridyl)methylamino]butane dimethobromide.
  • 5. The compound 1,5-bis[methyl-2-(3-dimethylcarbamoxypyridyl)methylamino]pentane dimethobromide.
  • 6. The compound 1,6-bis[methyl-2-(3-dimethylcarbamoxypyridyl)methylamino]hexane dimethobromide.
  • 7. The compound 1,7-bis[methyl-2-(3-dimethylcarbamoxypyridyl)methylamino]heptane dimethobromide.
  • 8. The compound 1,8-bis[methyl-2-(3-dimethylcarbamoxypyridyl)methylamino]octane dimethobromide.
  • 9. The compound 1,9-bis[methyl-2-(3-dimethylcarbamoxypyridyl)methylamino]nonane dimethobromide.
  • 10. The compound 1,10-bis[methyl-2-(3-dimethylcarbamoxypyridyl)methylamino]decane dimethobromide.
  • 11. The compound 1,11-bis[methyl-2-(3-dimethylcarbamoxypyridyl)methylamino]undecane dimethobromide.
US Referenced Citations (1)
Number Name Date Kind
3137702 Luttringhaus et al. Jun 1964